APOC3 and metabolic syndrome: It has been previously demonstrated that changes in the levels of apolipoprotein C-II (apoC-II) and apolipoprotein C-III (apoC-III) may be involved in the mechanisms underlying dyslipidemia in insulin resistance conditions.